In another study, integrin αvβ3, a protein that is overexpressed in many types of cancer cells, was targeted with cyclic arginine-glycine-aspartate (cRGD) by using maleimide-functionalized closo-dodecaborate albumin conjugate (MID-AC) with albumin. The gene discussed is ALB; the disease is cancer.